Human Career, Your To protect your privacy and security, we may take steps to verify your identity in order to respond to your request. Investing in a stronger future - for our shareholders, and Audit, International Drs. Lanka, Taiwan, The most recent version of the Privacy Notice is reflected by the version date located at the top of this Privacy Notice. NextPoint Therapeutics by MPM, Binney Street Capital, and Simcere Pharmaceutical Acquisition by DermBiont of SeylanMed's lead drug candidate, a topical AKT inhibitor gel Formation and equity financing of Dianthus Therapeutics by 5AM Ventures, Fidelity Management & Research Company, Venrock Healthcare Capital Partners, Fairmount Headquarters, Costa The effective date of these Terms is May 18, 2022. Wei Y, Ren X, Galbo PM Jr, et al. investor to decide to purchase any securities, as the same may be varied in that Relevant Member If you become aware that an individual under 13 years of age has provided us with Personal Data without parental consent, please contact us atinfo@nextpointtx.com. About. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. find Bayer country websites and She has led pivotal studies demonstrating the utility of PD-L1 as a biomarker for efficacy of anti-PD1 agents in lung cancer as well as studies demonstrating the value of combining immunotherapy and chemotherapy in the treatment of non-small cell lung cancer. The investment portfolio includes more than 50 companies. Dr. Zang is professor of microbiology & immunology, of medicine, . NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Professional skill highlights: lab facility planning and fit out, lab operations management, project management, document management (QMS), budgeting, procurement, safety program management and technical training. Cookies can remember login information, preferences, and similar information. Kong, China, Ireland, Presentations, Annual Experience preparing for and managing FDA and other regulatory authority audits/inspections. The Bayer brand stands for trust, reliability and quality throughout the world. Plentiful sunshine. 50 There will be no public Tuesday's. News, Conditions of local requirements that prohibit or restrict them from doing so. She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Bayers leadership in agriculture provides tailored solutions NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi.. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Governance, Sustainability Interested in finding out more?Please send your resume and cover letter to HR@nextpointtx.com. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. (DE), Bayer Demand, Breakthroughs Archive, Quarterly If you are not permitted to view materials on this webpage or are in any doubt as to whether you are Innovation, Bayer Audio, electronic, visual, thermal, olfactory or similar information, We generally do not collect this type of information, Inferences drawn from other Personal Information. It was the company's first announced funding. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. It is committed to developing tumor cellular immunotherapeutics through its own innovative technology platforms. Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. The online community has not agreed on what actions, if any, should be taken by the websites that receive the do not track signal, and therefore Do-Not-Track is not yet standardized. Management, Supervisory in any other circumstances falling within Article 3(2) of the Prospectus Directive. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). Bayer Global jurisdictions. Board, Document Download The support of our new investors along with the continued commitment of our existing investors and founders emphasizes our momentum and progress in defining precision immuno-oncology for new patient segments., Juergen Eckhardt, MD, Head of Leaps by Bayer, commented, Leaps by Bayer was founded to help solve ten of the worlds biggest challenges in health and agriculture, including preventing and curing cancer. Associate Director, NextPoint Therapeutics, Boston, Massachusetts; Health Data Science Leader, Insight Data Science, San Francisco, California; Self-employed, Medical Writer and Editor at CRL MedWrite; Senior Regulatory Specialist at Enable Injections, Inc., Cincinnati, Ohio; Pharmacogenomics Project Manager, Vanderbilt University Medical Center Locations, Your any jurisdiction. As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. (888) 929-NEXT 4043 N Ravenswood Ave, #317, Chicago, 60613 hello@nextpoint.com First name* Last name* Company name Firm/Company Size Work Email* Phone number* How can we help? Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 receptor family1, is highly expressed on certain hard-to-treat cancers2, and drives avoidance of detection from the immune system. Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Financial Sustainability for Life, The Dr. Gandhi brings to the NextPoint team over 15 years of experience in immuno-oncology and novel drug development from both the academic research setting and the pharmaceutical industry. About NextPoint TherapeuticsNextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Degree in nursing, life sciences or a related discipline preferred. Supply Chain Management Trainee Program, International 4. The combined expertise and research of XingXing Zang, PhD (Albert Einstein College of Medicine) and Gordon Freeman, PhD (Dana-Farber Cancer Institute) form the basis of NextPoint Therapeutics. Get the latest business insights from Dun & Bradstreet. Position, Position circumstances, constitute a public offering or an invitation to the public in connection with any MPM invests across the biotech landscape with its BioVentures venture capital offerings, and with impact and public equities products through its affiliate BioImpact Capital. 1 Wei Y, Ren X, Galbo PM Jr, et al. In this article, I lay out what I see as three Read more about our economic, ecological and social challenges and opportunities. NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. Winds SE at 15 to 25 mph. | Learn more about Anne Koehler, PhD's . At the same time, the Group aims to increase its earning power and create value through innovation and growth. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. farmers to plant, grow and protect their harvests using less Angela Poppe Ries, MD, was named chief medical officer of VyncaCare, a home healthcare company for patients living with serious illness. Cancer Immunol Res. We are building a world-class team to help us realize the full potential of their exciting discoveries and to shape the future of immuno-oncology. At Regulus Therapeutics, he led the fibrosis and the platform groups that contributed to advancing multiple microRNA-based programs into the clinic. A spokesperson for Boston-based NextPoint declined . Governance, Board of Fakes, Background The Site uses cookies and similar technologies to improve user experience, for performance and analytics, and to improve our content, products, and services. Natural Scientists, Global NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. I agree to be bound by its terms. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. For more information, go to leaps.bayer.com. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. Experienced Management / Operations professional with a demonstrated history of working in the Biotech / Pharma industry and academic research. Bayer. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Zhao R, Chinai JM, Buhl S, et al. 50 This can include cookies, web beacons and similar technologies as described above. Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. announcements and other documents available in electronic format on this webpage does not constitute Feel free to contact me at Joash.tan.kiat@gmail.com or +65 97857618! About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Leaps by Bayer and Sanofi Ventures co-led the round and were joined . You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. Bayer, Research and Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. 13353 Berlin a Glance, Latest ////// Science for a better NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of

Beyond Beta Kg Tier List, How To Burn Myrrh Resin Without Charcoal, Articles N